Abciximab (ReoPro) in Acute Ischemic Stroke "ReoPro"

Completed

Phase 2 Results

Eligibility Criteria

Inclusion Criteria

Patients presenting within 24 hours of stroke onset. Stratified for time since stroke onset (<12 vs >12 hrs) and stroke severity (NIH Stroke Score 4-14, >14).